# Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor

> **NCT03292458** · PHASE2,PHASE3 · COMPLETED · sponsor: **Kristina Simonyan** · enrollment: 117 (actual)

## Conditions studied

- Spasmodic Dysphonia
- Voice Tremor

## Interventions

- **DRUG:** Sodium Oxybate

## Key facts

- **NCT ID:** NCT03292458
- **Lead sponsor:** Kristina Simonyan
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-22
- **Primary completion:** 2021-12-29
- **Final completion:** 2024-10-11
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2025-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03292458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03292458, "Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03292458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*